Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Angiogenesis via exosome-mediated microRNA (miRNA) delivery is the process by which exosomes transport specific miRNAs to recipient cells, modulating gene expression and promoting the formation of new blood vessels. This mechanism is significant in physiological processes like tissue repair and pathological conditions such as cancer, ischemic diseases, and wound healing. Key pro-angiogenic miRNAs include miR-126 and miR-30b, while anti-angiogenic miRNAs include miR-497. The signaling pathways involved include PI3K/Akt, Notch, and ERK/MAPK.
Exosomes deliver microRNAs (miRNAs) to recipient cells, modulating gene expression post-transcriptionally, leading to altered angiogenic responses such as endothelial cell proliferation, migration, and tube formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Angiogenesis via Exosome-Mediated microRNA Delivery (None).